Brain metastases are a very common manifestation of cancer that have historically been
approached as a single disease entity given the uniform association with poor clinical …

Importance Small cell lung cancer (SCLC) is an aggressive disease that is characterized by
rapid growth and the early development of metastases. Patients typically respond to initial …

Radiotherapy is an important modality used for the treatment of lung cancer. Seventy‐seven
percent of all patients with lung cancer have an evidence‐based indication for radiotherapy …

Purpose Several sentinel phase III randomized trials have recently been published
challenging traditional radiation therapy (RT) practices for small cell lung cancer (SCLC) …

Small cell lung cancer (SCLC) is an aggressive high-grade neuroendocrine carcinoma.
Despite over 30 years of clinical research, little progress has been made in the management …

Radiotherapy (RT) plays a major role in the curative treatment of locally advanced non-small
cell lung cancer (NSCLC). Therefore, the ACROP committee was asked by the ESTRO to …

PURPOSE The American Society for Radiation Oncology (ASTRO) produced an evidence-
based guideline on radiation therapy (RT) for small-cell lung cancer (SCLC). Because of the …

Intruduction Radiation and immunotherapy have separately been shown to confer survival
advantages to patients with extensive-stage small cell lung cancer (ESCLC), but failure rates …

Unlike non-small-cell lung cancer (NSCLC), the progression of small-cell lung cancer
(SCLC) is slow. Extensive-stage SCLC (ES-SCLC) is a serious threat to human health, with …

Background To investigate the feasibility of integrating global radiomics and local deep
features based on multi-modal magnetic resonance imaging (MRI) for developing a …